JPS6153226A - 単純ヘルペスサブユニツトワクチンの精製方法 - Google Patents

単純ヘルペスサブユニツトワクチンの精製方法

Info

Publication number
JPS6153226A
JPS6153226A JP59177194A JP17719484A JPS6153226A JP S6153226 A JPS6153226 A JP S6153226A JP 59177194 A JP59177194 A JP 59177194A JP 17719484 A JP17719484 A JP 17719484A JP S6153226 A JPS6153226 A JP S6153226A
Authority
JP
Japan
Prior art keywords
hsv
vaccine
gel
subunit
affinity chromatography
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59177194A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0463863B2 (2
Inventor
Yoichiro Kino
洋一郎 城野
Hiroshi Mizogami
寛 溝上
Tetsuo Kawahara
川原　哲夫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP59177194A priority Critical patent/JPS6153226A/ja
Priority to KR1019850006051A priority patent/KR920009735B1/ko
Priority to AT85110643T priority patent/ATE54415T1/de
Priority to EP85110643A priority patent/EP0173268B1/en
Priority to DE8585110643T priority patent/DE3578617D1/de
Priority to CA000489367A priority patent/CA1251401A/en
Priority to US06/768,720 priority patent/US4724146A/en
Publication of JPS6153226A publication Critical patent/JPS6153226A/ja
Publication of JPH0463863B2 publication Critical patent/JPH0463863B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP59177194A 1984-08-24 1984-08-24 単純ヘルペスサブユニツトワクチンの精製方法 Granted JPS6153226A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP59177194A JPS6153226A (ja) 1984-08-24 1984-08-24 単純ヘルペスサブユニツトワクチンの精製方法
KR1019850006051A KR920009735B1 (ko) 1984-08-24 1985-08-22 단순 헤르페스 바이러스 서브유니트 왁진의 제조방법
AT85110643T ATE54415T1 (de) 1984-08-24 1985-08-23 Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit.
EP85110643A EP0173268B1 (en) 1984-08-24 1985-08-23 A method for the preparation of a herpes simplex virus subunit vaccine
DE8585110643T DE3578617D1 (de) 1984-08-24 1985-08-23 Verfahren zur herstellung eines impfstoffs einer herpes-simplex-virusuntereinheit.
CA000489367A CA1251401A (en) 1984-08-24 1985-08-23 Method for preparation of herpes simplex virus subunit vaccine
US06/768,720 US4724146A (en) 1984-08-24 1985-08-23 Method for preparation herpes simplex virus subunit vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59177194A JPS6153226A (ja) 1984-08-24 1984-08-24 単純ヘルペスサブユニツトワクチンの精製方法

Publications (2)

Publication Number Publication Date
JPS6153226A true JPS6153226A (ja) 1986-03-17
JPH0463863B2 JPH0463863B2 (2) 1992-10-13

Family

ID=16026819

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59177194A Granted JPS6153226A (ja) 1984-08-24 1984-08-24 単純ヘルペスサブユニツトワクチンの精製方法

Country Status (7)

Country Link
US (1) US4724146A (2)
EP (1) EP0173268B1 (2)
JP (1) JPS6153226A (2)
KR (1) KR920009735B1 (2)
AT (1) ATE54415T1 (2)
CA (1) CA1251401A (2)
DE (1) DE3578617D1 (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004532830A (ja) * 2001-02-23 2004-10-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン
JP2004536785A (ja) * 2001-02-23 2004-12-09 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5244792A (en) * 1984-04-06 1993-09-14 Chiron Corporation Expression of recombinant glyoprotein B from herpes simplex virus
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
US5585264A (en) * 1988-07-15 1996-12-17 University Of Saskatchewan Nucleotide sequences encoding recombinant bovine herpesvirus type-1 GI, GIII and GIV polypeptides
US5151267A (en) * 1988-07-15 1992-09-29 University Of Saskatchewan Bovine herpesvirus type 1 polypeptides and vaccines
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
US5447859A (en) * 1993-07-16 1995-09-05 Viagene Method for the purification or removal of retroviruses using sulfated cellulose
GB9804632D0 (en) * 1998-03-05 1998-04-29 Cantab Pharma Res Virus preparations and methods
AU2002302069B2 (en) * 1998-03-05 2007-11-15 Cantab Pharmaceuticals Research Limited Virus preparations and methods
US6342384B1 (en) * 1998-08-21 2002-01-29 The University Of Va Patent Foundation Production of adenoviral vectors using serum-free suspension cell culture in a hollow fiber system
DE10293048T1 (de) * 2001-04-27 2003-07-31 Glaxosmithkline Biolog Sa Neuer Impfstoff
US20070236809A1 (en) 2006-04-05 2007-10-11 Barret Lippey Forming spectral filters
TWI402606B (zh) 2007-05-09 2013-07-21 Dolby Lab Licensing Corp 三維影像之投影與觀看系統
US7784938B2 (en) 2007-05-09 2010-08-31 Dolby Laboratories Licensing Corporation Method and system for shaped glasses and viewing 3D images
US7959295B2 (en) 2007-05-18 2011-06-14 Dolby Laboratories Licensing Corporation Spectral separation filters for 3D stereoscopic D-cinema presentation
DE102013017014B4 (de) 2013-10-14 2017-03-30 Sartorius Stedim Biotech Gmbh Sulfatierte Cellulosehydrat-Membran, Verfahren zur ihrer Herstellung und Verwendung der Membran als Adsorptionsmembran für die Virenaufreinigung
US10809543B2 (en) 2017-01-23 2020-10-20 Dolby Laboratories Licensing Corporation Glasses for spectral and 3D imaging
CN111896731B (zh) * 2020-06-24 2023-06-09 宁波瑞源生物科技有限公司 一种化学发光免疫分析用清洗液

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
SE420977B (sv) * 1976-03-18 1981-11-16 Kabi Ab Forfarande for rening och isolering av hepatitvirus for vaccinframstellning
FI66020C (fi) * 1977-09-19 1984-08-10 Merck & Co Inc Foerfarande foer framstaellning av antigeniska immunogeniska subunits av hsv-1 och hsv-2
US4452734A (en) * 1980-02-11 1984-06-05 Merck & Co., Inc. Herpes subunit vaccine
US4317811A (en) * 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
US4762708A (en) * 1982-02-18 1988-08-09 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
DE3228501A1 (de) * 1982-07-30 1984-02-02 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines herpes-antigens, dazu geeignetes mittel sowie verfahren zu seiner herstellung und die verwendung dieses antigens
US4515714A (en) * 1983-03-09 1985-05-07 Juridicial Foundation, The Chemo-Semo-Sero-Therapeutic Research Institute Method for purification of hepatitis B virus surface antigen

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004532830A (ja) * 2001-02-23 2004-10-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン
JP2004536785A (ja) * 2001-02-23 2004-12-09 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン
US8557251B2 (en) 2001-02-23 2013-10-15 Glaxosmithkline Biologicals, Sa Non-live trivalent influenza vaccine for one-dose intradermal delivery

Also Published As

Publication number Publication date
ATE54415T1 (de) 1990-07-15
CA1251401A (en) 1989-03-21
EP0173268A2 (en) 1986-03-05
EP0173268B1 (en) 1990-07-11
KR870001837A (ko) 1987-03-28
US4724146A (en) 1988-02-09
JPH0463863B2 (2) 1992-10-13
KR920009735B1 (ko) 1992-10-22
EP0173268A3 (en) 1986-05-28
DE3578617D1 (de) 1990-08-16

Similar Documents

Publication Publication Date Title
JPS6153226A (ja) 単純ヘルペスサブユニツトワクチンの精製方法
AU609899B2 (en) Plasma and recombinant protein formulations in low ionic strength media
US4661349A (en) Herpes simplex virus subunit vaccine
EP0171086B1 (en) A method for purification of influenza virus
Luka et al. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines
JPH01149733A (ja) 高イオン性濃度媒体中の血漿及び組換え蛋白処方物
CA1251398A (en) Method for purification of rabic virus
JPH0662436B2 (ja) 静注用免疫グロブリン製剤の製造方法
US4164565A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
US4554157A (en) Hepatitis B vaccine
CZ279979B6 (cs) Způsob výroby před virem zabezpečeného, vysocečištěného faktoru VIII
US4118478A (en) Vaccine manufacture for active immunization containing hepatitis B surface antigen and associated antigen
US4118479A (en) Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
JPS5967226A (ja) ウイルス感染処置に使用する転移因子
Wyn-Jones et al. Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys
JP2926728B2 (ja) 蛋白質含有組成物の製造方法
Young et al. Preparation of hepatitis B polypeptide micelles from human carrier plasma
NL8220027A (nl) Therapeutisch middel voor de behandeling van allergische aandoeningen, immuno.complexziekten en tumoren.
Wohlfart et al. Human adenovirus 2 as immunogen in rabbits yields antisera with high titers of antibodies against the nonstructural 72K DNA-binding protein
JPH01301625A (ja) 因子８のゲル濾過法
JP3127232B2 (ja) 蛋白質製剤の製造法
Toyama et al. Inhibition of Sendai virus-induced hemolysis by concanavalin A
KR100258238B1 (ko) 대한민국형 씨(c)형 간염 바이러스의 특이항원인 외피 2씨(c) 단백질의 정제방법
JPH07503120A (ja) 細菌からの組換えアポリポタンパク質ｅの精製
JP2694419B2 (ja) ロタウイルス感染症の予防治療剤

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term